Prelude Capital Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $113K | Buy |
+12,942
| New | +$113K | 0.01% | 885 |
|
2025
Q1 | – | Sell |
-18,365
| Closed | -$167K | – | 1388 |
|
2024
Q4 | $167K | Buy |
+18,365
| New | +$167K | 0.01% | 903 |
|
2024
Q3 | – | Sell |
-48,178
| Closed | -$471K | – | 1430 |
|
2024
Q2 | $471K | Buy |
48,178
+7,044
| +17% | +$68.9K | 0.03% | 500 |
|
2024
Q1 | $621K | Buy |
41,134
+15,600
| +61% | +$236K | 0.03% | 478 |
|
2023
Q4 | $550K | Buy |
+25,534
| New | +$550K | 0.04% | 401 |
|
2023
Q3 | – | Sell |
-11,338
| Closed | -$287K | – | 1218 |
|
2023
Q2 | $287K | Sell |
11,338
-862
| -7% | -$21.8K | 0.02% | 574 |
|
2023
Q1 | $316K | Sell |
12,200
-1,269
| -9% | -$32.9K | 0.02% | 554 |
|
2022
Q4 | $319K | Buy |
+13,469
| New | +$319K | 0.02% | 671 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1814 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 1896 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 1904 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 1699 |
|
2021
Q1 | – | Sell |
-1,762
| Closed | -$352K | – | 1373 |
|
2020
Q4 | $352K | Buy |
+1,762
| New | +$352K | 0.01% | 464 |
|
2020
Q3 | – | Sell |
-5,877
| Closed | -$1.12M | – | 1824 |
|
2020
Q2 | $1.12M | Buy |
5,877
+5,177
| +740% | +$988K | 0.06% | 137 |
|
2020
Q1 | $109K | Buy |
+700
| New | +$109K | 0.01% | 343 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 1748 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 1557 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1721 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1727 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1660 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 1554 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 1559 |
|